Zymeworks Announces Participation in Upcoming Investor Conferences and Date of Third Quarter 2026 Financial Results
Globe Newswire•15/10/2026•06:00 ET
0
Key Highlights
- ➤Zymeworks (ZYME) will report Q3 2026 financial results November 9, 2026
- ➤No conference call or webcast planned for third-quarter results
- ➤Management scheduled investor meetings and fireside chats across four healthcare conferences
- ➤Certain conference fireside chats will offer live webcasts and replays
Zymeworks to Report Third Quarter 2026 Financial Results on November 9, 2026
VANCOUVER, British Columbia, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced that management will report its third quarter 2026 financial results after market close on November 9, 2026.
Get started
Create a free account to read the full story.